Ersoy Cholak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ersoy Cholak has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Annette Eva Langkilde
Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
2 shared publications - Bente Vestergaard
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
2 shared publications - Birthe Brandt Kragelund
REPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark
2 shared publications Katrine Bugge
Structural Biology and NMR Laboratory The Linderstrøm‐Lang Centre for Protein Science and Department of Biology University of Copenhagen Copenhagen Denmark
2 shared publications- Saskia Bucciarelli
Physical Chemistry, Department of Chemistry, Lund University , SE-22100 Lund, Sweden
2 shared publications Adree Khondker
Department of Physics and Astronomy McMaster University Hamilton ON Canada
1 shared publication
Latest Publications
- Open Access
- 11 April 2020
- Published by Wiley in The FASEB Journal
- Vol. 34 (6) , 7462-7482
Avidity within the N‐terminal anchor drives α‐synuclein membrane interaction and insertion
In the brain, α‐synuclein (aSN) partitions between free unbound cytosolic and membrane bound forms modulating both its physiological and pathological role and complicating its study due to structural heterogeneity. Here, we use an interdisciplinary, synergistic approach to characterize the properties of aSN:lipid mixtures, isolated aSN:lipid co‐structures, and aSN in mammalian cells. Enabled by the isolation of the membrane‐bound state, we show that within the previously described N‐terminal membrane anchor, membrane interaction relies both on an N‐terminal tail (NTT) head group layer insertion of 14 residues and a folded‐upon‐binding helix at the membrane surface. Both binding events must be present; if, for example, the NTT insertion is lost, the membrane affinity of aSN is severely compromised and formation of aSN:lipid co‐structures hampered. In mammalian cells, compromised cooperativity results in lowered membrane association. Thus, avidity within the N‐terminal anchor couples N‐terminal insertion and helical surface binding, which is crucial for aSN membrane interaction and cellular localization, and may affect membrane fusion.
- 11 April 2020
- Published by Wiley in The FASEB Journal
- Vol. 34 (6) , 7462-7482
Open AccessAvidity within the N‐terminal anchor drives α‐synuclein membrane interaction and insertion
In the brain, α‐synuclein (aSN) partitions between free unbound cytosolic and membrane bound forms modulating both its physiological and pathological role and complicating its study due to structural heterogeneity. Here, we use an interdisciplinary, synergistic approach to characterize the properties of aSN:lipid mixtures, isolated aSN:lipid co‐structures, and aSN in mammalian cells. Enabled by the isolation of the membrane‐bound state, we show that within the previously described N‐terminal membrane anchor, membrane interaction relies both on an N‐terminal tail (NTT) head group layer insertion of 14 residues and a folded‐upon‐binding helix at the membrane surface. Both binding events must be present; if, for example, the NTT insertion is lost, the membrane affinity of aSN is severely compromised and formation of aSN:lipid co‐structures hampered. In mammalian cells, compromised cooperativity results in lowered membrane association. Thus, avidity within the N‐terminal anchor couples N‐terminal insertion and helical surface binding, which is crucial for aSN membrane interaction and cellular localization, and may affect membrane fusion.
- 20 November 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (50) , 5052-5065
Distinct α-Synuclein:Lipid Co-Structure Complexes Affect Amyloid Nucleation through Fibril Mimetic Behavior
A hallmark of Parkinson’s disease is the presence of Lewy bodies consisting of lipids and proteins, mainly fibrillated α-synuclein (aSN). aSN is an intrinsically disordered protein exerting its physiological role in an ensemble of states, one of which coexisting in large assemblies with lipids, recently termed co-structures. Here, we decipher the kinetics of aSN:lipid co-structure formation to decode its mechanism of formation and we show that the co-structures form with distinct stoichiometry. Through seeded fibrillation assays, we demonstrate that aSN:lipid co-structures accelerate aSN fibril nucleation compared to lipid vesicles alone. A SAXS-based model is proposed in which aSN decorates the lipid vesicle surface obtaining properties similar to the fibril surface enhancing fibril nucleation. The delicate balance of aSN structural states close to and on the membrane may at given conditions, e.g. under increased local concentrations, be a crucial switching factor between functional and pathological behavior.
- 20 November 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (50) , 5052-5065
Distinct α-Synuclein:Lipid Co-Structure Complexes Affect Amyloid Nucleation through Fibril Mimetic Behavior
A hallmark of Parkinson’s disease is the presence of Lewy bodies consisting of lipids and proteins, mainly fibrillated α-synuclein (aSN). aSN is an intrinsically disordered protein exerting its physiological role in an ensemble of states, one of which coexisting in large assemblies with lipids, recently termed co-structures. Here, we decipher the kinetics of aSN:lipid co-structure formation to decode its mechanism of formation and we show that the co-structures form with distinct stoichiometry. Through seeded fibrillation assays, we demonstrate that aSN:lipid co-structures accelerate aSN fibril nucleation compared to lipid vesicles alone. A SAXS-based model is proposed in which aSN decorates the lipid vesicle surface obtaining properties similar to the fibril surface enhancing fibril nucleation. The delicate balance of aSN structural states close to and on the membrane may at given conditions, e.g. under increased local concentrations, be a crucial switching factor between functional and pathological behavior.